•
Mar 31, 2022

Selecta Biosciences Q1 2022 Earnings Report

Total Revenue
$34M
Previous year: $11.1M
+207.7%
EPS
$0.08
Previous year: -$0.22
-136.4%
Gross Profit
$34M
Previous year: $11.1M
+207.7%
Cash and Equivalents
$113M
Previous year: $125M
-9.5%
Free Cash Flow
-$12.3M
Previous year: -$12.2M
+1.3%
Total Assets
$146M
Previous year: $177M
-17.6%

Selecta Biosciences

Selecta Biosciences